Peptides9 min read
Selank versus benzodiazepines: what the human comparisons actually show
Small comparative studies exist, but they do not establish class-wide equivalence. Understand the medazepam, phenazepam and add-on evidence.
Read articleBlog
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides7 min read
Why Selank dependence claims need longer follow-up
Short symptom reports cannot prove long-term freedom from dependence. Separate tolerance, physical dependence, addiction and symptoms after stopping.
Read article
Peptides8 min read
What immune-cell markers can reveal, and what they leave unanswered
Cell counts, surface proteins and thymic-output markers can reveal biological activity. Learn why clinical outcomes still need their own evidence.
Read article
Peptides9 min read
Retatrutide and liver fat: impressive images are not the whole diagnosis
Retatrutide sharply reduced MRI-measured liver fat in a small substudy. That result differs from proving MASH resolution, fibrosis improvement or fewer liver complications.
Read article
Peptides9 min read
BPC-157 and blood-vessel growth: what it means for cancer questions
BPC-157 changes vessel behavior in laboratory studies. Learn why that raises specific research questions without settling long-term human cancer safety.
Read article
Peptides9 min read
Humanin and cancer: why cell survival can have tradeoffs
Humanin can support cell survival, but experimental tumor studies show why that effect needs cancer-specific scrutiny.
Read article
Peptides10 min read
What counts as a pet peptide study? Reading veterinary evidence without borrowing from rats
Feline exenatide studies show how species, disease stage, background care and measured outcomes determine what pet peptide research can actually tell owners.
Read article
Peptides9 min read
Does stimulating LH with kisspeptin establish a testosterone benefit?
Human studies show that kisspeptin can stimulate LH and testosterone. The clinical question is whether those signals lead to sustained, meaningful benefits.
Read article
Peptides9 min read
Thymosin alpha-1 and hepatitis: putting older trials in context
Older hepatitis studies tested specific viral and liver outcomes. Understand delayed responses, mixed results and the relevance to today's antiviral care.
Read article
Peptides8 min read
Can a TB-500 purity certificate settle what is in the vial?
A purity percentage answers only part of the product-quality question. Learn how identity, amount, microbial testing, and sample traceability differ.
Read article
Peptides8 min read
Petrelintide combinations: a plan is not a result
Animal experiments, formulation studies and human trials answer different questions about combining amylin and incretin medicines.
Read article
Peptides9 min read
LL-37 and autoimmune disease: why stronger immunity isn't the goal
LL-37 can help recognize microbes and participate in autoimmune inflammation. Explore what psoriasis, lupus and arthritis studies actually show.
Read article145–156 of 321 articles